- 期刊
- OpenAccess
Safety and Efficacy of Imidapril in the Treatment of Essential Hypertension
並列摘要
Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are one of the renin angiotensin system (RAS) inhibitors widely used for the treatment of hypertension. Recently, Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC) meta-analysis showed that ACEIs had the blood pressure independent beneficial effects on coronary heart events. In this review, we summarized our current knowledge about ACEIs especially imidapril and re-evaluated ACEIs among other RAS inhibitors (RASIs) because ACEIs have wide ranges of beneficial effects in addition to the ACE inhibition which other RASIs do not have such as the up-regulation of bradykinin level, substance P level, the inhibition of matrix metalloproteinase (MMP) activity and stabilization of coronary plaque.
延伸閱讀
- Papademetriou, V., Tsioufis, C., Gradman, A., & Punzi, H. (2011). Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies. International Journal of Hypertension, 2011(), 366-369. https://doi.org/10.4061/2011/438198
- 卓士傑、李春璟、李文賢、朱俊源、許栢超、蘇河名、林宗憲、溫文才、賴文德、許勝雄（2014）。The Current Prevalence, Possible Pathogenesis and Management of Resistant Hypertension。內科學誌，25(4)，231-237。https://doi.org/10.6314/JIMT.2014.25(4).01
- Zhang, W., & Li, N. (2011). Prevalence, Risk Factors, and Management of Prehypertension. International Journal of Hypertension, 2011(), 570-575. https://doi.org/10.4061/2011/605359
- Jiang, J. (2021). Prevention and Research of Hypertension in Human Clinical. World Scientific Research Journal, 7(9), 183-187. https://doi.org/10.6911/WSRJ.202109_7(9).0025
- Sande, F. V. D., & Kooman, J. (2015). Intra-Dialytic Hypertension: Pathophysiological Mechanisms and Treatment Options. Acta Nephrologica, 29(2), 51-57. https://doi.org/10.6221/AN.2015010